Endymed (Israel) Top Management

ENDY Stock   330.00  2.00  0.60%   
Endymed employs about 41 people. The company is managed by 37 executives with a total tenure of roughly 256 years, averaging almost 6.0 years of service per executive, having 1.11 employees per reported executive. Analysis of Endymed's management performance can provide insight into the company performance.
Yoram Hert  CEO
CEO, Endymed Medical Ltd.
Amy Kamin  CEO
CEO of EndyMed USA
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Endymed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Endymed Management Team Effectiveness

The company has return on total asset (ROA) of 0.0385 % which means that it generated a profit of $0.0385 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2146 %, meaning that it generated $0.2146 on every $100 dollars invested by stockholders. Endymed's management efficiency ratios could be used to measure how well Endymed manages its routine affairs as well as how well it operates its assets and liabilities.

Endymed Workforce Comparison

Endymed is one of the top stocks in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 15,885. Endymed adds roughly 41.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.06 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.06.

Endymed Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Endymed Price Series Summation is a cross summation of Endymed price series and its benchmark/peer.

Endymed Notable Stakeholders

An Endymed stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Endymed often face trade-offs trying to please all of them. Endymed's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Endymed's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Daniel LischinskyFounder and VP of RandDProfile
Yoram HertCEO, Endymed Medical Ltd.Profile
Amy KaminCEO of EndyMed USAProfile
Elad MagalCEOProfile
Yosef BarOnCEOProfile
Amir SchoriVice President - Business DevelopmentProfile
Rami AviramVice President - FinanceProfile
Sima WitmanVice President - Research & DevelopmentProfile
Oren MaymonVice President - OperationsProfile
Lior CohenVice President of SalesProfile
Atzmon ShlushVice President - OperationsProfile
Eran IshayVice President - Research & DevelopmentProfile
Daniel LishinskyVice President - Research & DevelopmentProfile
Zvika LifschitzVice President - FinanceProfile
Ben FeldmanCFOProfile
Amiram GoldmanExternal DirectorProfile
Eran NaorExternal Director, Independent DirectorProfile
Ronen ZadokExternal DirectorProfile
Yoram HarthFounder, Director & Chief Medical OfficerProfile
Yuan YibingDirectorProfile
Batsheva ElranDirectorProfile
Jan JingranDirectorProfile
Sharon DovevDirector of MarketingProfile
Lior ViderExternal DirectorProfile
Idan AlfaFinance DirectorProfile
Yocheved DvirDirectorProfile
Annie JinDirectorProfile
Lee RothFinance DirectorProfile
Ofer ZviDirectorProfile
Lee GabayControllerProfile
Yossi CPAChief OfficerProfile
Sima WeissmanVP RDProfile
Joseph LevtzlerClinical VPProfile
Bill ScottPres IncProfile
Moshe CohenInternal AuditorProfile
Frank IannelliCorporate ExecutiveProfile
Amir GanunVP MarketingProfile

About Endymed Management Performance

The success or failure of an entity such as Endymed often depends on how effective the management is. Endymed management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Endymed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Endymed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Endymed Ltd was founded in 2007 and is based in New York, New York. ENDYMED LTD operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange.
The data published in Endymed's official financial statements usually reflect Endymed's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Endymed. For example, before you start analyzing numbers published by Endymed accountants, it's critical to develop an understanding of what Endymed's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Endymed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Endymed's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Endymed's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Endymed. Please utilize our Beneish M Score to check the likelihood of Endymed's management manipulating its earnings.

Endymed Workforce Analysis

Traditionally, organizations such as Endymed use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Endymed within its industry.

Endymed Manpower Efficiency

Return on Endymed Manpower

Revenue Per Employee531.3K
Revenue Per Executive588.7K
Net Income Per Employee125.9K
Net Income Per Executive139.5K
Working Capital Per Employee122K
Working Capital Per Executive135.1K
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Endymed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Endymed Stock analysis

When running Endymed's price analysis, check to measure Endymed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Endymed is operating at the current time. Most of Endymed's value examination focuses on studying past and present price action to predict the probability of Endymed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Endymed's price. Additionally, you may evaluate how the addition of Endymed to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Global Correlations
Find global opportunities by holding instruments from different markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Please note, there is a significant difference between Endymed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Endymed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Endymed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.